Tailored design and synthesis of heparan sulfate oligosaccharide analogues using sequential one-pot multienzyme systems.
Tailored design and synthesis of heparan sulfate oligosaccharide analogues using sequential one-pot multienzyme systems.
复制标题
DOI:
10.1002/anie.201305667
复制
发表时间:
2013-11-04
影响因子:
16.6
通讯作者:
Chen, Xi
中科院分区:
文献类型:
--
作者:
Chen, Yi;Li, Yanhong;Yu, Hai;Sugiarto, Go;Thon, Vireak;Hwang, Joel;Ding, Li;Hie, Liana;Chen, Xi
Heparan sulfate (HS) and heparin are linear sulfated heteropolysaccharides consisting of alternating α1–4-linked D-glucosamine (GlcN) and 1–4-linked uronic acid (α-linkage for L-iduronic acid, IdoA, and β-linkage for D-glucuronic acid, GlcA). Possible modifications are 2-O-sulfation on the uronic acid residues and one or more modifications on the glucosamine residues including N-sulfation, N-acetylation, 6-O-sulfation, and 3-O-sulfation. Heparin and low molecular weight heparin (LMWH) are the most commonly used anticoagulants or antithrombotic drugs. Compared to HS, heparin has a higher level of sulfation and a higher IdoA content.[1] Heparin is mostly produced by mast cells and heparan sulfates are produced by different cell types in animals.[2] They are attractive synthetic targets due to the therapeutic application of heparin, and the important roles of HS and heparin in regulating cancer growth, blood coagulation, inflammation, assisting viral and bacterial infections, signal transduction, lipid metabolism, and cell differentiation.[3]Synthetic heparins can eliminate the side effects caused by inherent heterogeneous heparins purified from natural sources. Their synthesis, however, possesses great synthetic challenges due to their structural complexity. Although much progress has been made over the last decade on the synthesis, analysis, and understanding of complex HS and heparin, the mechanisms for the formation and regulation of HS/heparin and the structure-function relationship of complex HS/heparin are still not fully understood.[2] A tailor-made synthetic process is still lacking.
登录
查看更多内容
影响因子:
5
作者:
Li, Yanhong;Yu, Hai;Thon, Vireak;Chen, Yi;Muthana, Musleh M.;Qu, Jingyao;Hie, Liana;Chen, Xi
通讯作者:
Chen, Xi
影响因子:
2.7
作者:
Chen, Chen;Yu, Biao
通讯作者:
Yu, Biao
影响因子:
3
作者:
Ojeda, R;Terentí, O;Martín-Lomas, M
通讯作者:
Martín-Lomas, M
影响因子:
15
作者:
Arungundram, Sailaja;Al-Mafraji, Kanar;Asong, Jinkeng;Leach, Franklin E., III;Amster, I. Jonathan;Venot, Andre;Turnbull, Jeremy E.;Boons, Geert-Jan
通讯作者:
Boons, Geert-Jan
影响因子:
15
作者:
de Paz, JL;Noti, C;Seeberger, PH
通讯作者:
Seeberger, PH